Clinical trial
Study for Newly Diagnosed Follicular Lymphoma Patients With a Large Tumor Burden
NCT00136552 · Lymphoma Study Association, Other · Completed
Key facts
| NCT number | NCT00136552 |
|---|---|
| Title | Study for Newly Diagnosed Follicular Lymphoma Patients With a Large Tumor Burden |
| Official title | FL-2000 Study for Newly Diagnosed Follicular Lymphoma Patients With a High Tumor Burden |
| Lead sponsor | Lymphoma Study Association, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Drug |
| Interventions | rituximab |
| Enrollment | 360 |
| Start date | May 1, 2000 |
| Completion | Dec 1, 2004 |
| First posted | Aug 29, 2005 |
| Last update posted | Jul 3, 2007 |
| Countries | Belgium, France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: